Gilles Gasser

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 218 publications

Synthesis and Antiparasitic Activities of New Organometallic Derivatives of the Benzimidazole Anthelmintic Drugs.

Synthesis and Antiparasitic Activities of New Organometallic Derivatives of the Benzimidazole Anthelmintic Drugs.

Journal: Chembiochem : a European journal of chemical biology

Published: May 30, 2026

Harnessing Immunogenic PANoptosis With Iridium(III) Biradical Photosensitizers for Melanoma Photoimmunotherapy.

Harnessing Immunogenic PANoptosis With Iridium(III) Biradical Photosensitizers for Melanoma Photoimmunotherapy.

Journal: Angewandte Chemie (International ed. in English)

Published: April 28, 2026

Correction to "Three in One: In Vitro and In Vivo Evaluation of Anticancer Activity of a Theranostic Agent that Combines Magnetic Resonance Imaging, Optical Bioimaging, and Photodynamic Therapy Capabilities".

Correction to "Three in One: In Vitro and In Vivo Evaluation of Anticancer Activity of a Theranostic Agent that Combines Magnetic Resonance Imaging, Optical Bioimaging, and Photodynamic Therapy Capabilities".

Journal: ACS applied bio materials

Published: April 21, 2026

Leveraging Morphological Profiling for Mechanistic Elucidation of Metal-Based Anticancer Compounds.

Leveraging Morphological Profiling for Mechanistic Elucidation of Metal-Based Anticancer Compounds.

Journal: JACS Au

Published: March 11, 2026

Synthesis, Characterization, and Evaluation of Chelators for Radium-223.

Synthesis, Characterization, and Evaluation of Chelators for Radium-223.

Journal: Inorganic chemistry

Published: March 04, 2026

A Deep-Red-Absorbing Osmium(II) Complex as a Photosensitizer for Photodynamic Therapy Inducing Immunogenic Cell Death.

A Deep-Red-Absorbing Osmium(II) Complex as a Photosensitizer for Photodynamic Therapy Inducing Immunogenic Cell Death.

Journal: Angewandte Chemie (International ed. in English)

Published: February 02, 2026

Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020-2025).

Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020-2025).

Journal: Chemical communications (Cambridge, England)

Published: January 22, 2026

Organelle-Targeting Iridium(III) Benzothiazole Complexes Potently Induce Immunogenic Cell Death for Gastric Cancer Immunotherapy.

Organelle-Targeting Iridium(III) Benzothiazole Complexes Potently Induce Immunogenic Cell Death for Gastric Cancer Immunotherapy.

Journal: Journal of medicinal chemistry

Published: January 12, 2026

Design, Synthesis, and Evaluation of Organic and Organometallic Pyrazoline Derivatives as Selective Dual COX-2/5-LOX Inhibitors and Potential Anticancer Agents.

Design, Synthesis, and Evaluation of Organic and Organometallic Pyrazoline Derivatives as Selective Dual COX-2/5-LOX Inhibitors and Potential Anticancer Agents.

Journal: Journal of medicinal chemistry

Published: January 07, 2026

Towards a dual copper(II) and iron(III) transmetalation strategy for an anticancer application with the deferasirox chelator.

Towards a dual copper(II) and iron(III) transmetalation strategy for an anticancer application with the deferasirox chelator.

Journal: Journal of inorganic biochemistry

Published: December 18, 2025

Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinoma.

Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinoma.

Journal: Journal of medicinal chemistry

Published: November 19, 2025

Selective, controlled release of ruthenium-based therapeutic agents: a targeted weapon against ovarian cancer

Selective, controlled release of ruthenium-based therapeutic agents: a targeted weapon against ovarian cancer

Journal: Medecine sciences : M/S

Published: November 19, 2025

Showing 1-12 of 218

Last Updated: 09/26/2026